ESR1 and endometrium adenocarcinoma: ER-positivity did not clearly explain GYS1 expression levels, although recent studies in other cell types, e.g., endometrial adenocarcinoma cells and rat astrocytes, demonstrated that estradiol stimulates GYS1 expression [42, 43].